Plain-English translation of NCT07610772 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Denmark
Germany
Safety & dosing
Sponsor
Aarhus University Hospital
Collaborators
Charite University, Berlin, Germany
Enrollment target
~15 participants
Started
April 2026
Primary completion
April 2028
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ole Schmeltz Søgaard, MD, PhD, professor
Aarhus University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.